Further, to understand the prevalence and importance of genetic mutations of the GPCR-mediated PI3K pathway in other types of human cancers, we comprehensively analyzed the largest cohort of TCGA data from pan-cancer cell lines (n = 1080) and pan-tumor samples (n = 9020). Here, PIK3CA is linked to neoplasm.